Eastern Cooperative Oncology Group

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 2012-01-01

Employees: 51

Market Cap: -

Website: https://ecog-acrin.org

Clinical Trials

Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

First Posted Date: 2006-10-13

Last Posted Date: 2015-04-28

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 79

Registration Number: NCT00387699

Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

Phase 2

Completed

Conditions: Carcinoma of Unknown Primary
Pain

First Posted Date: 2006-07-27

Last Posted Date: 2020-11-02

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 52

Registration Number: NCT00357630

Locations: 🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
🇺🇸
Memorial Hospital of South Bend, South Bend, Indiana, United States

and more 34 locations

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2

Terminated

Conditions: Lymphoma

Interventions: Biological: Rituximab
Drug: Cytarabine
Drug: Dexamethasone
Drug: Leucovorin
Drug: Methotrexate
Drug: Procarbazine
Drug: Vincristine

First Posted Date: 2006-06-08

Last Posted Date: 2023-07-03

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 26

Registration Number: NCT00335140

Locations: 🇺🇸
West Michigan Cancer Center, Kalamazoo, Michigan, United States
🇺🇸
Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States
🇺🇸
Bronson Methodist Hospital, Kalamazoo, Michigan, United States

and more 65 locations

Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance

Completed

Conditions: Cognitive/Functional Effects
Psychosocial Effects of Cancer and Its Treatment
Spiritual Concerns
Cancer Survivor
Sexuality and Reproductive Issues
Breast Cancer

First Posted Date: 2006-04-03

Last Posted Date: 2023-06-18

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 2697

Registration Number: NCT00309933

Locations: 🇺🇸
St. Luke's Regional Medical Center, Sioux City, Iowa, United States
🇺🇸
Borgess Medical Center, Kalamazoo, Michigan, United States
🇺🇸
Bronson Methodist Hospital, Kalamazoo, Michigan, United States

and more 101 locations

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Completed

Conditions: Psychosocial Effects of Cancer and Its Treatment
Cognitive/Functional Effects
Lung Cancer
Prostate Cancer
Breast Cancer
Pain
Colorectal Cancer

First Posted Date: 2006-03-17

Last Posted Date: 2023-06-18

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 2310

Registration Number: NCT00303914

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸
Saint Joseph Regional Medical Center, South Bend, Indiana, United States

and more 29 locations

Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: rituximab
Biological: filgrastim
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: carboplatin
Drug: prednisone
Drug: etoposide
Drug: vincristine
Drug: ifosfamide

First Posted Date: 2006-01-11

Last Posted Date: 2023-06-29

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 100

Registration Number: NCT00274924

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
Mason District Hospital, Havana, Illinois, United States
🇺🇸
Greater Baltimore Medical Center Cancer Center, Baltimore, Maryland, United States

and more 99 locations

Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

Phase 2

Withdrawn

Conditions: Gastrointestinal Carcinoid Tumor
Islet Cell Carcinoma

First Posted Date: 2005-09-28

Last Posted Date: 2015-10-08

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00227773

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: bevacizumab
Drug: cyclophosphamide
Drug: doxorubicin
Drug: prednisone
Drug: vincristine

First Posted Date: 2005-09-22

Last Posted Date: 2023-06-18

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 46

Registration Number: NCT00217425

Locations: 🇺🇸
Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States
🇺🇸
Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States
🇺🇸
California Cancer Care, Incorporated - Greenbrae, Greenbrae, California, United States

and more 107 locations

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Biological: cetuximab

First Posted Date: 2005-02-08

Last Posted Date: 2023-06-28

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 72

Registration Number: NCT00103207

Locations: 🇺🇸
St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
🇺🇸
Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus, Boca Raton, Florida, United States
🇺🇸
Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States

and more 154 locations

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Phase 2

Withdrawn

Conditions: Adult Acute Erythroid Leukemia
Adult Acute Monoblastic and Acute Monocytic Leukemia
Adult Acute Myeloid Leukemia

First Posted Date: 2005-01-10

Last Posted Date: 2017-10-19

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00101140

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy